Cidara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WETZEL INVESTMENT ADVISORS, INC. | 08/07/2024 | 4,000 | $3,680 | 0.00% | 0.09% |
| JPMORGAN CHASE & CO | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| US BANCORP \DE\ | 08/07/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 10/17/2024 | 0 | $0 | -100.00% | 0.00% |
| MACKENZIE FINANCIAL CORP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| BVF INC/IL | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| PRUDENTIAL FINANCIAL INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MARINER, LLC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 07/19/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CALLAN CAPITAL, LLC | 10/22/2024 | 0 | $0 | -100.00% | 0.00% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 07/24/2024 | 0 | $0 | -100.00% | 0.00% |
| PURE FINANCIAL ADVISORS, LLC | 07/18/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| FNY INVESTMENT ADVISERS, LLC | 08/05/2024 | 0 | $0 | -100.00% | 0.00% |
| LIBERTY WEALTH MANAGEMENT LLC | 08/07/2024 | 0 | $0 | -100.00% | 0.00% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| PACIFICA PARTNERS INC. | 07/11/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| JEPPSON WEALTH MANAGEMENT, LLC | 08/05/2024 | 0 | $0 | -100.00% | 0.00% |
| LEGACY WEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SPIRE WEALTH MANAGEMENT | 07/31/2024 | 0 | $0 | -100.00% | 0.00% |
| WEST MICHIGAN ADVISORS, LLC | 08/05/2024 | 0 | $0 | -100.00% | 0.00% |
| PALE FIRE CAPITAL SE | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
Cidara Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 12 institutional investors and hedge funds held shares of Cidara Therapeutics, Inc.. The most heavily invested institutionals were:
WETZEL INVESTMENT ADVISORS, INC.: 0
BlackRock Inc.: 0
KNOTT DAVID M: 415,308
Aisling Capital LLC: 891,614
BB BIOTECH AG: 2.3 M
Opera Trading Capital: 0
0.09% of Cidara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.19 M shares in the last 24 months. This purchase volume represents approximately $96.85 M in transactions.